{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:34:49Z","timestamp":1789587289454,"version":"build-2803163510"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"23","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,14]]},"DOI":"10.1093\/eurheartj\/ehx764","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T04:10:27Z","timestamp":1513224627000},"page":"2208-2216","source":"Crossref","is-referenced-by-count":97,"title":["Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials"],"prefix":"10.1093","volume":"39","author":[{"given":"Timothy D","family":"Henry","sequence":"first","affiliation":[{"name":"Cedars-Sinai Heart Institute, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W","family":"Losordo","sequence":"additional","affiliation":[{"name":"Caladrius Biosciences, Inc., New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H","family":"Traverse","sequence":"additional","affiliation":[{"name":"Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Schatz","sequence":"additional","affiliation":[{"name":"Scripps Clinic Torrey Pines, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Marc","family":"Jolicoeur","sequence":"additional","affiliation":[{"name":"Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L","family":"Schaer","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Clare","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chiswell","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"White","sequence":"additional","affiliation":[{"name":"Ochsner Clinical School, Ochsner Medical Center, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F David","family":"Fortuin","sequence":"additional","affiliation":[{"name":"Mayo Clinic Hospital, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J","family":"Kereiakes","sequence":"additional","affiliation":[{"name":"The Christ Hospital Heart and Vascular Center, Lindner Research Center, Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M","family":"Zeiher","sequence":"additional","affiliation":[{"name":"University of Frankfurt, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Sherman","sequence":"additional","affiliation":[{"name":"LoneStar Heart Inc., Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S","family":"Hunt","sequence":"additional","affiliation":[{"name":"Shire US, Lexington, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Povsic","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"key\n\t\t\t\t20180614045811_ehx764-B1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0002-9149(99)00387-2","article-title":"Direct myocardial revascularization and angiogenesis\u2013how many patients might be eligible?","volume":"84","author":"Mukherjee","year":"1999","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ccd.22431","article-title":"Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality","volume":"75","author":"Williams","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B3","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.cjca.2011.10.015","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"28","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B5","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.cjca.2011.07.007","article-title":"Management of patients with refractory angina: Canadian Cardiovascular Society\/Canadian Pain Society joint guidelines","volume":"28","author":"McGillion","year":"2012","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B6","first-page":"412","volume-title":"Chronic Coronary Artery Disease: A Companion to Braunwald\u2019s Heart Disease","author":"Jolicoeur","year":"2017"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B7","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary","volume":"126","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B8","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mhj.2001.115786","article-title":"Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization","volume":"142","author":"Mukherjee","year":"2001","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B10","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B11","doi-asserted-by":"crossref","first-page":"e001287.","DOI":"10.1161\/JAHA.114.001287","article-title":"Predictors of long-term clinical endpoints in patients with refractory angina","volume":"4","author":"Povsic","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B13","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","article-title":"CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells","volume":"114","author":"Kawamoto","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B14","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ahj.2013.03.003","article-title":"A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study","volume":"165","author":"Povsic","year":"2013","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial: efficacy and safety of intramyocardial autologous CD34(+) cell administration in patients with refractory angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3727\/096368916X691484","article-title":"Autologous CD34+ cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study","volume":"25","author":"Henry","year":"2016","journal-title":"Cell Transplant"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (efficacy of ranolazine in chronic angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B20","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B22","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/hrt.2002.008144","article-title":"Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease","volume":"90","author":"Eizawa","year":"2004","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B24","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.jacc.2007.08.033","article-title":"Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity","volume":"50","author":"Povsic","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B26","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/gerona\/glt067","article-title":"Lower levels of circulating progenitor cells are associated with low physical function and performance in elderly men with impaired glucose tolerance: a pilot substudy from the VA Enhanced Fitness trial","volume":"68","author":"Povsic","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/gerona\/glv180","article-title":"Endothelial progenitor cell levels predict future physical function: an exploratory analysis from the VA enhanced fitness study","volume":"71","author":"Povsic","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.116.304187","article-title":"Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease","volume":"116","author":"Patel","year":"2015","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B29","doi-asserted-by":"crossref","first-page":"e64669.","DOI":"10.1371\/journal.pone.0064669","article-title":"Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis","volume":"8","author":"Fisher","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis","volume":"118","author":"Khan","year":"2016","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjcard.2013.03.021","article-title":"Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy","volume":"112","author":"Kandala","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cjca.2012.12.003","article-title":"Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials","volume":"29","author":"Li","year":"2013","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000320217","article-title":"Intracoronary autologous CD34+ stem cell therapy for intractable angina","volume":"117","author":"Wang","year":"2010","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCRESAHA.115.308165","article-title":"PreSERVE-AMI: a randomized, double-blind, placebo-controlled clinical trial of intracoronary administration of autologous CD34+ cells in patients with left ventricular dysfunction post STEMI","volume":"120","author":"Quyyumi","year":"2017","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180614045811_ehx764-B35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ Res"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/39\/23\/2208\/25041404\/ehx764.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T18:15:40Z","timestamp":1719684940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/39\/23\/2208\/4791398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":35,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2018,1,5]]},"published-print":{"date-parts":[[2018,6,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx764","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,14]]},"published":{"date-parts":[[2018,1,5]]}}}